(1)
Kostiukova, N.; Fishchuk, L.; Rossokha, Z.; Medvedieva, N.; Andreieva, S.; Bloshchinska, S.; Popova, O.; Vydyborets, S.; Gorovenko, N. CYP2C19*2 Gene Variant (G681A, rs4244285) As a Prognostic Marker for the Clinical Course of Multiple Myeloma. Exp. oncol. 2023, 43, 336-340.